Inactive Instrument

Press Releases Clovis Oncology, Inc.

Equities

CLVS.Q

US1894641000

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Clovis Oncology : D.I. 616, 823, 848, 884 - Form 8-K	23-07-11	PU
Clovis Oncology : Modification to Rights of Security Holders - Form 8-K	23-06-30	PU
Clovis Oncology : Regulation FD Presentation - Form 8-K	23-06-02	PU
Clovis Oncology : UNITED STATES BANKRUPTCY COURT - Form 8-K	23-05-03	PU
Clovis Oncology : Acquisition/Asset Disposal - Form 8-K	23-04-14	PU
Clovis Oncology : Regulation FD Presentation - Form 8-K	23-03-02	PU
Clovis Oncology : Regulation FD Presentation - Form 8-K	23-02-13	PU
CLOVIS ONCOLOGY, INC. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	22-12-19	AQ
CLOVIS ONCOLOGY, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	22-12-13	AQ
CLOVIS ONCOLOGY, INC. : Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Other Events, Financial Statements and Exhibits (form 8-K)	22-12-13	AQ
Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286	22-12-12	BU
Clovis Oncology : Accelaration/Increase of Financial Obligation - Form 8-K	22-12-02	PU
CLOVIS ONCOLOGY, INC. : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Other Events (form 8-K)	22-12-02	AQ
CLOVIS ONCOLOGY, INC. : Other Events (form 8-K)	22-11-16	AQ
Clovis: Q3 Earnings Snapshot	22-11-09	AQ
CLOVIS ONCOLOGY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-09	AQ
Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific Retreat	22-10-27	BU
Clovis Oncology Highlights Updated LuMIERE Phase 1 Data of Targeted Radiotherapy Candidate FAP-2286 at the 35th Annual EANM Congress	22-10-17	BU
TRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM Mutations	22-10-03	BU
Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement	22-09-21	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Clovis Oncology, Inc.

Equities

CLVS.Q

US1894641000

Press Releases

Filters